GB1437006A - Antidistemper and anti-hepatitis vaccines - Google Patents

Antidistemper and anti-hepatitis vaccines

Info

Publication number
GB1437006A
GB1437006A GB2551673A GB2551673A GB1437006A GB 1437006 A GB1437006 A GB 1437006A GB 2551673 A GB2551673 A GB 2551673A GB 2551673 A GB2551673 A GB 2551673A GB 1437006 A GB1437006 A GB 1437006A
Authority
GB
United Kingdom
Prior art keywords
distemper
antidistemper
hepatitis
hepatitis vaccines
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2551673A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1437006A publication Critical patent/GB1437006A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00—Speech recognition
    • G10L15/22—Procedures used during a speech recognition process, e.g. man-machine dialogue
    • G10L2015/226—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
    • G10L2015/227—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB2551673A 1972-05-26 1973-05-29 Antidistemper and anti-hepatitis vaccines Expired GB1437006A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Publications (1)

Publication Number Publication Date
GB1437006A true GB1437006A (en) 1976-05-26

Family

ID=5845894

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2551673A Expired GB1437006A (en) 1972-05-26 1973-05-29 Antidistemper and anti-hepatitis vaccines

Country Status (13)

Country Link
US (1) US3886270A (cg-RX-API-DMAC7.html)
AR (1) AR201193A1 (cg-RX-API-DMAC7.html)
AT (1) AT336779B (cg-RX-API-DMAC7.html)
AU (1) AU467451B2 (cg-RX-API-DMAC7.html)
BE (1) BE800132A (cg-RX-API-DMAC7.html)
CA (1) CA1020461A (cg-RX-API-DMAC7.html)
DE (1) DE2225548C3 (cg-RX-API-DMAC7.html)
DK (1) DK141055C (cg-RX-API-DMAC7.html)
FR (1) FR2189023B1 (cg-RX-API-DMAC7.html)
GB (1) GB1437006A (cg-RX-API-DMAC7.html)
NL (1) NL163428C (cg-RX-API-DMAC7.html)
SE (1) SE7608007L (cg-RX-API-DMAC7.html)
ZA (1) ZA733571B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US5000951A (en) * 1987-03-09 1991-03-19 Diamond Scientific Company Multivalent canine distemper virus vaccine
CN105884889A (zh) * 2016-04-18 2016-08-24 内蒙古神元生物工程股份有限公司 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
AU5612573A (en) 1974-11-28
NL7306986A (cg-RX-API-DMAC7.html) 1973-11-28
AR201193A1 (es) 1975-02-21
SE7608007L (sv) 1976-07-13
NL163428C (nl) 1980-09-15
AT336779B (de) 1977-05-25
FR2189023A1 (cg-RX-API-DMAC7.html) 1974-01-25
ZA733571B (en) 1974-04-24
NL163428B (nl) 1980-04-15
DK141055B (da) 1979-12-31
DE2225548B2 (de) 1979-09-06
FR2189023B1 (cg-RX-API-DMAC7.html) 1976-12-03
ATA459273A (de) 1976-09-15
CA1020461A (en) 1977-11-08
BE800132A (fr) 1973-11-28
US3886270A (en) 1975-05-27
DE2225548C3 (de) 1980-05-29
DE2225548A1 (de) 1973-12-06
DK141055C (da) 1980-06-23
AU467451B2 (en) 1975-12-04

Similar Documents

Publication Publication Date Title
AU506385B2 (en) Hepatitis b virus; isolation for vaccines
NL930133I2 (nl) Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin.
HU9502949D0 (en) Polipeptides, polinucleotides, vectors and host cells, and vaccines against hepatitis virus infection, diagnostics, immunoassay and culturing methods
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
FI823021A7 (fi) Tuotteet, jotka osoittavat hepatitis B virus e antigeenin antigeenisuuden ja menetelmät näiden antigeenien vavalmistamiseksi.
AU504454B2 (en) Hepatitis b antigen and vaccine
DE3268361D1 (en) New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process
FI102616B1 (fi) Menetelmä rokotteen valmistamiseksi ihmisen parainfluenssa-viruksen tyyppiä 3 varten ja menetelmässä käytettävä ilmentämisjärjestelmä
NL189207B (nl) Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis.
FI833205A7 (fi) Menetelmä hepatitis B-virusrokotteen valmistamiseksi.
TW340873B (en) Chicken anaemia agent vaccine
GB1437006A (en) Antidistemper and anti-hepatitis vaccines
ZA761346B (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
AU1807776A (en) Detecting hepatitis antigen and antibodies and vaccine for hepatitis
NL7602621A (nl) Werkwijze voor het bereiden van een vaccin tegen virale hepatitis.
CA961410A (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
CA983851A (en) Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same
ZA803845B (en) Polyvalent virus vaccines
GB1538704A (en) Inactivated equine rhinopneumonitis virus vaccine
EP0339668A3 (en) Hepatitis a virus antigen
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
JPS51118825A (en) A process for preparing heat stable iga and igm
NL188982B (nl) Werkwijze voor het bereiden van een vaccin tegen hepatitis a.
EP0293201A3 (en) Method of vaccination for hepatitis b virus

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee